We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUJAR
9476
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$300 ﹤0.01%
+3,000
New +$313
MSPRW
9477
DELISTED
MSP Recovery Inc Warrant
MSPRW
$294 ﹤0.01%
98,083
+94,304
+2,495% +$217
PRAY icon
9478
FIS Christian Stock Fund
PRAY
$81.7M
$289 ﹤0.01%
10
-200
-95% -$6.01K
ADTX
9479
DELISTED
ADITXT INC
ADTX
0
HAPY
9480
DELISTED
Harbor Human Capital Factor Unconstrained ETF
HAPY
$285 ﹤0.01%
+12
New +$292
ICU icon
9481
SeaStar Medical
ICU
$13.1M
$281 ﹤0.01%
+15
New +$428
BARK.WS
9482
DELISTED
BARK Inc Warrants
BARK.WS
$280 ﹤0.01%
+3,419
New +$303
APOC
9483
Innovator Equity Defined Protection ETF - 6mo Apr/Oct
APOC
$70.1M
$280 ﹤0.01%
+11
New +$279
EUDAW icon
9484
EUDA Health Holdings Warrant
EUDAW
$226K
$277 ﹤0.01%
+2,493
New +$250
MSFU icon
9485
Direxion Daily MSFT Bull 2X ETF
MSFU
$1.18B
$276 ﹤0.01%
+7
New +$296
ZVIA icon
9486
Zevia
ZVIA
$111M
$272 ﹤0.01%
65
+49
+306% +$100
OACP icon
9487
OneAscent Core Plus Bond ETF
OACP
$267M
$270 ﹤0.01%
+12
New +$275
JUNS
9488
Jupiter Neurosciences
JUNS
$3.93M
0
PSNYW icon
9489
Polestar Automotive Holding ADS Class C-1
PSNYW
$387M
$267 ﹤0.01%
64
-204
-76% -$1.18K
ALOY
9490
REalloys Inc
ALOY
$837M
$266 ﹤0.01%
+121
New +$315
QNXT
9491
iShares Nasdaq-100 ex Top 30 ETF
QNXT
$29.2M
$266 ﹤0.01%
+11
New +$278
MUSQ icon
9492
MUSQ Global Music Industry ETF
MUSQ
$21.7M
$261 ﹤0.01%
+11
New +$262
AUUDW
9493
DELISTED
Auddia Inc Warrants
AUUDW
$257 ﹤0.01%
10,280
-1,972
-16% -$54
AUUD
9494
Auddia
AUUD
$4.41M
$254 ﹤0.01%
4
-78
-95% -$5.93K
ZSL icon
9495
ProShares UltraShort Silver
ZSL
$52.3M
$252 ﹤0.01%
1
-405
-100% -$149K
RMNY
9496
Rockefeller New York Municipal Bond ETF
RMNY
$28.1M
$249 ﹤0.01%
+10
New +$252
LEXX icon
9497
Lexaria Bioscience
LEXX
$8.71M
$244 ﹤0.01%
+8
New +$295
NIOBW
9498
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$242 ﹤0.01%
2,607
-454
-15% -$58
SJB icon
9499
ProShares Short High Yield
SJB
$47.7M
$242 ﹤0.01%
15
-6,143
-100% -$100K
AKTX
9500
Akari Therapeutics
AKTX
$12.3M
$237 ﹤0.01%
+5
New +$376

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.